Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Administration Aids”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Post-approval studies (Phase 4)Study completedNCT04388904
What this trial is testing

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Who this might be right for
HIV-1-infection
The Crofoot Research Center, Inc. 75
Not applicableStudy completedNCT00312832
What this trial is testing

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV InfectionsLipoatrophy
Hospital Clinic of Barcelona 60
Large-scale testing (Phase 3)Study completedNCT00547898
What this trial is testing

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

Who this might be right for
HIV Associated Diarrhea
Bausch Health Americas, Inc. 374
Large-scale testing (Phase 3)Study completedNCT00002178
What this trial is testing

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 375
Early research (Phase 1)Study completedNCT00295477
What this trial is testing

Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV

Who this might be right for
HIV
University of Pennsylvania 25
Early research (Phase 1)Study completedNCT04484337
What this trial is testing

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 138
Early research (Phase 1)Study completedNCT05933824
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects

Who this might be right for
Hiv
Shanxi Kangbao Biological Product Co., Ltd. 36
Large-scale testing (Phase 3)UnknownNCT01715922
What this trial is testing

Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa

Who this might be right for
Cryptococcal MeningitisHIV
ANRS, Emerging Infectious Diseases 41
Not applicableStudy completedNCT00762320
What this trial is testing

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Who this might be right for
HIV Infections
Phoenix Children's Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00838162
What this trial is testing

Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

Who this might be right for
Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 33
Early research (Phase 1)Study completedNCT01348516
What this trial is testing

Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

Who this might be right for
Human Immunodeficiency Virus
Kainos Medicine Inc. 83
Early research (Phase 1)Study completedNCT00114699
What this trial is testing

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

Who this might be right for
HIV Infections
Human Genome Sciences Inc. 40
Not applicableNot Yet RecruitingNCT07175545
What this trial is testing

Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine

Who this might be right for
Dose Administration AidsMedication AdherencePolypharmacy+3 more
Lusofona University 96
Large-scale testing (Phase 3)UnknownNCT01540240
What this trial is testing

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients

Who this might be right for
HIVZidovudine Adverse Reaction
University Hospital, Geneva 136
Early research (Phase 1)Study completedNCT00386347
What this trial is testing

Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 56
Early research (Phase 1)Study completedNCT04757974
What this trial is testing

Low-dose Fostemsavir Extended Release Relative Bioavailability Study

Who this might be right for
HIV Infections
ViiV Healthcare 32
Large-scale testing (Phase 3)Study completedNCT02671383
What this trial is testing

Evaluation of Low-dose Darunavir in a Switch Study

Who this might be right for
HIV Infections
Willem Daniel Francois Venter 300
Large-scale testing (Phase 3)Ended earlyNCT00612898
What this trial is testing

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Who this might be right for
HIV Infections
Avexa 239
Not applicableApproved For MarketingNCT00097799
What this trial is testing

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT02249130
What this trial is testing

Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

Who this might be right for
HIV Infections
Boehringer Ingelheim 18
Load More Results